2019
DOI: 10.1016/j.drugalcdep.2018.09.022
|View full text |Cite
|
Sign up to set email alerts
|

Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
131
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 159 publications
(132 citation statements)
references
References 45 publications
1
131
0
Order By: Relevance
“…Pharmacists should realize that electronic resources like PDMPs are one of several tools to be used together to evaluate opioid misuse risk and to maintain patient engagement. Some PDMPs and supply‐side policies may potentially end up unintentionally harming patients if not combined with expansion of treatment and harm reduction interventions like naloxone …”
Section: Discussionmentioning
confidence: 99%
“…Pharmacists should realize that electronic resources like PDMPs are one of several tools to be used together to evaluate opioid misuse risk and to maintain patient engagement. Some PDMPs and supply‐side policies may potentially end up unintentionally harming patients if not combined with expansion of treatment and harm reduction interventions like naloxone …”
Section: Discussionmentioning
confidence: 99%
“…Surgeons may prescribe a large amount of opioid medications after surgery for convenience [1,3,12e15]. Some states have introduced legislation with prescription limits in an attempt to reduce the amount of available opioids for potential diversion and misuse [16]. A 2014 Cochrane review concluded that opioids pose a relatively high risk for long-term dependence and subsequent withdrawal when compared to other pain medications [17].…”
mentioning
confidence: 99%
“…Some of these initiatives include legislative changes through guideline recommendations in opioid prescribing for chronic, non-cancer pain, acute pain conditions, and prescription monitoring programs (42,67). Research examining these changes have suggested that there is a decrease in opioid prescribing with these measures in place such as using the recommendation of nonsteroidal anti-inflammatory drugs (NSAIDs) over opioids for acute pain (28,(67)(68)(69)(70). These findings in combination with the ever-changing synthetic opioids drug market would suggest that is important to continue to tailor recommendations to fit the everchanging opioid user.…”
Section: Summary Of Evidencementioning
confidence: 99%